AI Medical Compendium Journal:
Lung cancer (Amsterdam, Netherlands)

Showing 11 to 19 of 19 articles

Development and validation of a clinically applicable deep learning strategy (HONORS) for pulmonary nodule classification at CT: A retrospective multicentre study.

Lung cancer (Amsterdam, Netherlands)
PURPOSE: To propose a practical strategy for the clinical application of deep learning algorithm, i.e., Hierarchical-Ordered Network-ORiented Strategy (HONORS), and a new approach to pulmonary nodule classification in various clinical scenarios, i.e....

Lung cancer prediction by Deep Learning to identify benign lung nodules.

Lung cancer (Amsterdam, Netherlands)
INTRODUCTION: Deep Learning has been proposed as promising tool to classify malignant nodules. Our aim was to retrospectively validate our Lung Cancer Prediction Convolutional Neural Network (LCP-CNN), which was trained on US screening data, on an in...

A cross-modal 3D deep learning for accurate lymph node metastasis prediction in clinical stage T1 lung adenocarcinoma.

Lung cancer (Amsterdam, Netherlands)
OBJECTIVES: The evaluation of lymph node (LN) status by radiologists based on preoperative computed tomography (CT) lacks high precision for early lung cancer patients; erroneous evaluations result in inappropriate therapeutic plans and increase the ...

Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients.

Lung cancer (Amsterdam, Netherlands)
OBJECTIVES: A malignant pleural effusion (MPE) is a common complication in non-small cell lung cancer (NSCLC) with important staging and prognostic information. Patients with MPEs are often candidates for advanced therapies, however, the current gold...

Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results.

Lung cancer (Amsterdam, Netherlands)
OBJECTIVES: We evaluated whether machine learning may be helpful for the detection of lung cancer in FDG-PET imaging in the setting of ultralow dose PET scans.

Radiomics and radiogenomics in lung cancer: A review for the clinician.

Lung cancer (Amsterdam, Netherlands)
Lung cancer is responsible for a large proportion of cancer-related deaths across the globe, with delayed detection being perhaps the most significant factor for its high mortality rate. Though the National Lung Screening Trial argues for screening o...

Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion.

Lung cancer (Amsterdam, Netherlands)
OBJECTIVES: Malignant pleural effusion (MPE) has a poor prognosis. Most patients are treated with tube thoracostomy and sclerotherapy, although its success rate is around 64%. We have investigated intrapleural perfusion with hyperthermic chemotherapy...

Artificial intelligence in predicting EGFR mutations from whole slide images in lung Cancer: A systematic review and Meta-Analysis.

Lung cancer (Amsterdam, Netherlands)
BACKGROUND: Epidermal growth factor receptor (EGFR) mutations play a pivotal role in guiding targeted therapy for lung cancer, making their accurate detection essential for personalized treatment. Recently, artificial intelligence (AI) has emerged as...